Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Stock Report

| More

Injecting Hope: TCS Debuts a People-Centric Solution for COVID-19 Testing and Vaccine Management

Posted On: 2021-03-03 21:52:17 (Time Zone: Arizona, USA)


Tata Consultancy Services (TCS) (BSE: 532540, NSE: TCS), a leading global IT services, consulting and business solutions organization, has announced the launch of the TCS COVID-19 Testing and Vaccine Management Suite. This suite of modular, easy-to-deploy solutions streamlines every stage of the end-to-end testing and vaccination journeys, enabling more individuals to get tested and vaccinated faster and return to normal life experiences.

Behind every vaccination or test for COVID-19 isthe highly complex orchestration of multiple stakeholders - from manufacturing to transportation, allocation to storage, distribution to scheduling, and reporting to monitoring. There is an opportunity to provide a seamless process across the entire value chain to prevent issues that could slow down testing and vaccinations.

In designing its new solution suite, TCS emulated the example of successful retailers and other consumercentric enterprises and adopted their proven, people-centric approach to optimizing the testing and vaccination ecosystems. Further, given the urgency of the problem, re-purposing proven use cases from other consumer-facing industries helped speed up the design of an end-to-end solution.

"The pandemic is changing our world in many ways, driving stakeholder collaboration across industries that share a commitment to getting testing and vaccines to everyone," said Debashis Ghosh, Business Group Head - Life Sciences, Healthcare and Public Sector, TCS. "TCS' suite of COVID-19 Testing and Vaccine Management solutions is built to enable transparency, ease of access, and equity that will collectively accelerate a return to normalcy."

The TCS COVID-19 Testing and Vaccine Management Suite leverages AI, robotics, blockchain and the Internet of Things (IoT), as well as TCS' extensive network of leading technology partners. This suite transforms all five stages of the testing and vaccination journeys: research & manufacture, allocate & transport, store & distribute, schedule & administer, and monitor & re-open. It enables ecosystem participants at each of these stages to seamlessly share critical information among themselves while complying with privacy and consent regulations, and to scale up their operations so communities receive the required quantities of tests and vaccines. The suite includes the following key capabilities:

Research & Manufacture: A drug development platform for life sciences companies that provides faster access to new vaccines. The platform is powered by TCS' cognitive AI engine, data driven smart analytics and IoT to make clinical trials more agile and safe.

Allocate & Transport: Ensures secure transfer of controlled pharmaceuticals with real-time track and trace, and temperature monitoring through IoT and blockchain technology that integrates with ERP systems, and machine learning to monitor and optimize vaccine shipments.

Store & Distribute: Addresses challenges with the vaccine supply chain, including demand planning, supply visibility, and cold-storage handling. Enables digital ecosystems to provide faster access to vaccines.

Schedule & Administer: Improves customer engagement and provides transparency to vaccine administration and scheduling. Supports transportation coordination, contactless experiences, and patient surveys.

Monitor & Re-open: Offers an interoperable analytics platform that provides a view of patients and their vaccinations. In addition, the platform facilitates seamless travel, public gatherings, and safe office environments via secure orchestration of mandatory testing and inoculation data across stakeholders.

The COVID-19 Testing and Vaccine Management Suite is powered by TCS PACE™, which brings together the best of TCS' innovation assets and practices.

Shares of TATA CONSULTANCY SERVICES LTD. was last trading in BSE at Rs.3058.65 as compared to the previous close of Rs. 3010.55. The total number of shares traded during the day was 206125 in over 13362 trades.

The stock hit an intraday high of Rs. 3063.45 and intraday low of 2996.5. The net turnover during the day was Rs. 626159215.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Other Headlines:

Subex to launch new AI Automation Platform on April 22, 2021

Easy Trip Planners Ltd board declares interim dividend of Rs. 2

Firstsource Solutions Ltd board to consider Q4, FY21 results on May 11, 2021

Happiest Minds wins Times Ascent - World HRD Congress HR Excellence Awards 2021

Indian Energy Exchange commences Cross Border Electricity Trade through its platform

Caplin Steriles gets USFDA approval for Milrinone Lactate Injection

NTPC Ltd declares commercial operation of 85 MW Bilhaur Solar PV Project

G E Shipping takes delivery of a Secondhand Midsize Gas Carrier 'Jag Vikram'

Copenhagen Fintech welcomes Infosys to Elevate Fintech Innovation

Ambuja 'Kawach' recognized globally by Solar Impulse Foundation's efficient solution label

India Ratings assigns Sobha 'IND AA-'/Stable

Sarda Energy & Minerals Ltd updates on Madhya Bharat Power Corporation Ltd

Can Fin Homes Ltd board to consider dividend, Q4, FY21 results on April 30, 2021

HCL to drive end-to-end IT transformation at UD Trucks

WeP Solutions Ltd rights issue to close today

IFGL Refractories Ltd board to consider FY21 results, dividend on May 22, 2021

United Breweries Ltd board to recommend dividend, consider Q4, FY21 results on April 27, 2021

Goa Carbon Limited temporarily shuts down Goa unit for maintenance from April 17, 2021

Sonata Software Ltd board to approve Q4, FY2021 results on May 12, 2021

KPIT Technologies Ltd board to consider dividend, Q4, FY21 results on April 28, 2021

Macrotech Developers Ltd to list on April 19, 2021

KSB Ltd board to approve Q1CY21 results on April 28, 2021

INOX Leisure Limited Ratings downgraded to 'CRISIL A+/Negative/CRISIL A1'

Bhansali Engineering Polymers Ltd Board approves dividend of Rs. 1 for FY21

All Wonderla Amusement Parks will open only on Friday, Saurday and Sunday from April 19, 2021

Bhansali Engineering Polymers Ltd Q4FY21 consolidated PAT jumps to Rs. 163.48 crore

Kalyan Jewellers ushers in the wedding season with its latest Muhurat Campaign

IndusInd Bank Ltd board to consider Q4, FY21 results on April 30, 2021

Jubilant Ingrevia Ltd appoints two directors to its board

Wockhardt Ltd board to consider raising funds through NCDs on April 21, 2021

Trident Ltd celebrating Mission Day with a special discount coupon to shareholders

S.P. Capital Financing Ltd approves selling of shares in Pride And Expert Properties Private Limited

IIFL Securities Limited to acquire Category II AIF from IIFL Wealth Management Ltd

HDFC Bank Limited to raise up to Rs. 50,000 crore

Indo Asian Finance Ltd to consider allotment of 60 lakh shares on April 20, 2021

KEC International Limited Resumption of WKTL Transmission Project

IIFL Wealth Management Ltd to sell AIF Category-II business to IIFL Management Services Ltd

International Travel House Ltd Q4FY21 loss at Rs. 6.70 crore

Gujarat Hotels Ltd Q4FY21 net profit slides YoY, QoQ

ICICI Lombard General Insurance Company Limited board recommends final dividend of Rs. 4

Gujarat Hotels Ltd board recommends dividend of Rs. 1.80 for FY21

ICICI Lombard General Insurance Company Ltd reports Rs. 345.68 crore PAT in Q4FY21

HDFC Bank Ltd's gross NPAs at 1.32%, reduces QoQ

HDB Financial Services Ltd's gross NPAs at 3.9% as of March 31, 2021

HDFC Securities Ltd reports PAT of Rs. 253.1 crore in Q4FY21

Career Point signed MOU with Ministry of Social Justice and Empowerment for tutorial services

HDFC Bank's balance sheet increases 14.1% YoY

Indiamart arm to acquire 22% in Truckhall Pvt Ltd

HDFC Bank Ltd Q4FY21 consolidated net profit slips QoQ to Rs. 8433.78 crore

CRISIL downgrades rating of PVR Ltd


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020